Related Experiment Video
Updated: May 22, 2025
07:41
Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
Published on: October 23, 2020
5.6K
Diabetic Striatopathy: A Treatable Movement Disorder
Gurunathan Srinivasan1, P Vishaal2, M Chozhan3
1MBBS Student, Department of Neurology, Stanley Medical College, Chennai, Tamil Nadu, India, Orcid: https://orcid.org/0000-0001-5606-102X.
The Journal of the Association of Physicians of India
|March 15, 2025
Summary
Diabetic striatopathy (DS), a rare complication of diabetes, causes involuntary movements like hemichorea-hemiballismus syndrome (HCHB). Effective glycemic control and medication significantly improved symptoms in a recent case study.
Area of Science:
- Neurology
- Endocrinology
- Medical Case Studies
Background:
- Diabetic striatopathy (DS) is a rare complication of diabetes mellitus.
- It is characterized by hemichorea-hemiballismus syndrome (HCHB) associated with hyperglycemia.
Purpose of the Study:
- To present a case study of diabetic striatopathy.
- To detail the clinical presentation, imaging, and treatment of DS.
- To emphasize the importance of glycemic control in managing DS.
Main Methods:
- A case study of a 60-year-old woman with poorly regulated diabetes was analyzed.
- Clinical signs, evolution, and imaging characteristics of DS were documented.
- Treatment involved glycemic control and medication.
Main Results:
- The patient presented with persistent involuntary hyperkinetic movements.
- Treatment led to notable improvement in symptoms.
- Imaging results were distinct and contributed to diagnosis.
Conclusions:
- Prompt identification and effective treatment are crucial for managing diabetic striatopathy.
- Glycemic management is a cornerstone in the treatment of DS.
- This case contributes to understanding and managing DS.
Related Concept Videos
01:24Parkinson's Disease: Treatment
174
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
174
01:15Parkinson's Disease: Overview
410
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
410
01:15Diabetes: Management and Pharmacotherapy
220
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
220
01:15Diabetes: Symptoms, Diagnosis, and Complications
495
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
495
01:22Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K